Omega-3 deficiency and neurodegeneration in the substantia nigra: Involvement of increased nitric oxide production and reduced BDNF expression

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 6, 2014, Pages 1902-1912

  Cardoso, Henriqueta Dias ^a   Santos Junior, Eraldo Fonseca Dos ^a   De Santana, David Filipe ^a   Gonçalves Pimentel, Catarina ^a   Angelim, Monara Kaélle ^a   Isaac, Alinny R ^a   Lagranha, Cláudia Jacques ^b   Guedes, Rubem Carlos Araújo ^c   Beltrão, Eduardo Isidoro ^a   Morya, Edgar ^d   Rodrigues, Marcelo Cairrão Araújo ^a   Andrade Da Costa, Belmira Lara Da Silveira ^a  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Federal University of Pernambuco   (Brazil)

^d Instituto Internacional de Neurociência de Natal Edmond e Lily Safra   (Brazil)

Author keywords

Brain derived neurotrophic factor; Docosahexaenoic acid; Dopamine; Lipoperoxidation; Oxidative stress; Striatum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATALASE; NITRIC OXIDE; OMEGA 3 FATTY ACID; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ESSENTIAL FATTY ACID DEFICIENCY; FEMALE; LIPID PEROXIDATION; MALE; MOLECULAR PATHOLOGY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SUBSTANTIA NIGRA;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; DOPAMINE; LIPOPEROXIDATION; OXIDATIVE STRESS; STRIATUM;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATALASE; FATTY ACIDS, OMEGA-3; FEMALE; LIPID PEROXIDATION; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PARKINSON DISEASE; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE; TYROSINE 3-MONOOXYGENASE;

EID: 84896962011     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.12.023     Document Type: Article

References (71)

1. R. Hassler Zur pathologie der paralysis agitans und des postencephalitschen Parkinsonismus Psychol. Neurol. 48 1938 387 476
2. T. Gonzalez-Hernandez et al. Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease Front. Neuroanat. 4 2010 140
3. P.M. Kidd Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management Altern. Med. Rev. 5 2000 502 545
4. L.J. Lawson et al. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neuroscience 39 1 1990 151 170
5. L. Minghetti et al. Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration Adv. Exp. Med. Biol. 468 1999 109 119 (Pubitemid 32197925)
6. A.J. Duncan, and S.J. Heales Nitric oxide and neurological disorders Mol. Aspects Med. 26 1-2 2005 67 96 (Pubitemid 40250165)
7. K.S. Madathil et al. Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats Neurochem. Int. 62 5 2013 674 683
8. T. Arimoto, and G. Bing Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration Neurobiol. Dis. 12 1 2003 35 45 (Pubitemid 36259966)
9. T. Gonzalez-Hernandez, P. Abdala, and M. Rodriguez NOS expression in nigral cells after excitotoxic and non-excitotoxic lesion of the pedunculopontine tegmental nucleus Eur. J. Neurosci. 9 12 1997 2658 2667 (Pubitemid 28082955)
10. V. Calabrese et al. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity Nat. Rev. Neurosci. 8 10 2007 766 775 (Pubitemid 47462116)
11. A.R. West, and K.Y. Tseng Nitric oxide-soluble guanylyl cyclase-cyclic GMP signaling in the striatum: new targets for the treatment of Parkinson's disease? Front. Syst. Neurosci. 5 2011 55
12. S. Delion et al. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex J. Neurochem. 66 4 1996 1582 1591
13. S. Chalon Omega-3 fatty acids and monoamine neurotransmission Prostaglandins Leukot. Essent. Fatty Acids 75 4-5 2006 259 269 (Pubitemid 44442912)
14. L. Zimmer et al. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids J. Lipid Res. 41 1 2000 32 40 (Pubitemid 30051839)
15. S.O. Ahmad et al. Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study Neurosci. Lett. 438 3 2008 303 307
16. P.P. Passos et al. Dopaminergic cell populations of the rat substantia nigra are differentially affected by essential fatty acid dietary restriction over two generations J. Chem. Neuroanat. 44 2 2012 66 75
17. M. Bousquet et al. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease FASEB J. 22 4 2008 1213 1225 (Pubitemid 351519975)
18. M. Cansev et al. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease Neurosci. Res. 62 3 2008 206 209
19. G. Tanriover et al. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease Folia Histochem. Cytobiol. 48 3 2010 434 441
20. M. Bousquet et al. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model Prog. Neuropsychopharmacol. Biol. Psychiatry 33 8 2009 1401 1408
21. A. Vines et al. The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism Neuropharmacology 62 1 2012 184 191
22. Z. Ying et al. Dietary omega-3 deficiency from gestation increases spinal cord vulnerability to traumatic brain injury-induced damage PLoS One 7 12 2012 e52998
23. C. Hyman et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 6315 1991 230 232 (Pubitemid 21912205)
24. K. Stahl et al. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease Brain Res. 1378 2011 105 118
25. M. Abe et al. Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice Cell. Mol. Neurobiol. 30 6 2010 917 928
26. C.M. Gall et al. Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons Mol. Cell. Neurosci. 3 1 1992 56 63
27. H.A. Boger et al. Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging Genes Brain Behav. 10 2 2011 186 198
28. S. Singh et al. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease Indian J. Exp. Biol. 44 9 2006 699 704 (Pubitemid 44369299)
29. C.A. Altar, and P.S. DiStefano Neurotrophin trafficking by anterograde transport Trends Neurosci. 21 10 1998 433 437 (Pubitemid 28449073)
30. T. Tsukahara et al. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys Neurosurgery 37 4 1995 733 739 (discussion 739-41)
31. D.W. Howells et al. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Exp. Neurol. 166 1 2000 127 135
32. M. Mogi et al. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neurosci. Lett. 270 1 1999 45 48 (Pubitemid 29322994)
33. M. Baydyuk, M.T. Nguyen, and B. Xu Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration Exp. Neurol. 228 1 2011 118 125
34. H.D. Cardoso et al. Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids Front. Hum. Neurosci. 6 2012 249
35. M.C. Soares et al. Effect of essential fatty acid deficiency on membrane fatty acid content and growth hormone stimulation of rat pituitaries during postnatal development J. Lipid Res. 36 6 1995 1401 1406
36. H.J. Deuel Jr. et al. The effect of fat level of the diet on general nutrition. XIV. Further studies of the effect of hydrogenated coconut oil on essential fatty acid deficiency in the rat J. Nutr. 55 2 1955 337 346
37. A.D. Paixao et al. Renal effects of essential fatty acid deficiency in hydropenic and volume-expanded rats Kidney Blood Press. Res. 25 1 2002 27 33 (Pubitemid 34136839)
38. K.M. Hargrave, M.J. Azain, and J.L. Miner Dietary coconut oil increases conjugated linoleic acid-induced body fat loss in mice independent of essential fatty acid deficiency Biochim. Biophys. Acta 1737 1 2005 52 60 (Pubitemid 41550383)
39. P.R. Ling et al. Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet Prostaglandins Leukot. Essent. Fatty Acids 83 4-6 2010 229 237
40. P.C. de Velasco et al. Nutritional restriction of omega-3 fatty acids alters topographical fine tuning and leads to a delay in the critical period in the rodent visual system Exp. Neurol. 234 1 2012 220 229
41. F.E. Randall, M.A. Whittington, and M.O. Cunningham Fast oscillatory activity induced by kainate receptor activation in the rat basolateral amygdala in vitro Eur. J. Neurosci. 33 5 2011 914 922
42. A.T. Davis The use of isoflurane anaesthesia in studies of carnitine metabolism in the laboratory rat Lab. Anim. 30 4 1996 377 382 (Pubitemid 26393455)
43. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 2 1979 351 358 (Pubitemid 9194347)
44. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 10 1972 3170 3175
45. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
46. L.C. Green et al. Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids Anal. Biochem. 126 1 1982 131 138 (Pubitemid 13203451)
47. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press Inc.
48. E.M. Glaser, and P.D. Wilson The coefficient of error of optical fractionator population size estimates: a computer simulation comparing three estimators J. Microsc. 192 Pt. 2 1998 163 171 (Pubitemid 28539620)
49. Y. Xiao, Y. Huang, and Z.Y. Chen Distribution, depletion and recovery of docosahexaenoic acid are region-specific in rat brain Br. J. Nutr. 94 4 2005 544 550 (Pubitemid 41555495)
50. B. Levant, J.D. Radel, and S.E. Carlson Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in n-3 polyunsaturated fatty acids Biol. Psychiatry 60 9 2006 987 990 (Pubitemid 44584204)
51. J.M. Borba et al. Essential fatty acid deficiency reduces cortical spreading depression propagation in rats: a two-generation study Nutr. Neurosci. 13 3 2010 144 150
52. A. Ahmad et al. A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus Nutr. Neurosci. 5 2 2002 103 113 (Pubitemid 34303213)
53. M. Pierucci et al. Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders CNS Neurol. Disord. Drug Targets 10 7 2011 777 791
54. S. Singh, and M. Dikshit Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide Brain Res. Rev. 54 2 2007 233 250 (Pubitemid 46891075)
55. M. Sarsilmaz et al. Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum Prostaglandins Leukot. Essent. Fatty Acids 69 4 2003 253 259 (Pubitemid 37463806)
56. E.A. Del Bel et al. Role of nitric oxide on motor behavior Cell. Mol. Neurobiol. 25 2 2005 371 392 (Pubitemid 40768440)
57. M.Z. Gomes, R. Raisman-Vozari, and E.A. Del Bel A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway Brain Res. 1203 2008 160 169
58. V. Di Matteo et al. Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study Ann. N. Y. Acad. Sci. 1155 2009 309 315
59. D.Y. Lu et al. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids Neuropsychopharmacology 35 11 2010 2238 2248
60. F. Kuperstein, R. Eilam, and E. Yavin Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency J. Neurochem. 106 2 2008 662 671
61. A. Bishop, R. Gooch, A. Eguchi, S. Jeffrey, L. Smallwood, J. Anderson, and A.G. Estevez Mitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of induced adaptive NO resistance in the CNS Neurochem. 109 1 2009 74 84
62. D.C. Duke et al. The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability Neurogenetics 8 2 2007 83 94 (Pubitemid 46356249)
63. C. Hyman et al. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon J. Neurosci. 14 1 1994 335 347
64. J.S. Rao et al. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex Mol. Psychiatry 12 2 2007 151 157 (Pubitemid 46160980)
65. S.I. Rapoport, J.S. Rao, and M. Igarashi Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver Prostaglandins Leukot. Essent. Fatty Acids 77 5-6 2007 251 261 (Pubitemid 350214520)
66. D. Miyazawa et al. Regional differences of the mouse brain in response to an alpha-linolenic acid-restricted diet: neurotrophin content and protein kinase activity Life Sci. 87 15-16 2010 490 494
67. H. Katsuki et al. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling J. Neurochem. 110 2 2009 707 718
68. J. Lengqvist et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain Mol. Cell. Proteomics 3 7 2004 692 703 (Pubitemid 39077000)
69. D.S. Castro et al. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells J. Biol. Chem. 276 46 2001 43277 43284
70. F. Volpicelli et al. BDNF gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro J. Neurochem. 102 2 2007 441 453 (Pubitemid 47000587)
71. J. Jankovic, S. Chen, and W.D. Le The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease Prog. Neurobiol. 77 1-2 2005 128 138 (Pubitemid 41654775)